Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386725951> ?p ?o ?g. }
- W4386725951 abstract "Neoadjuvant chemo-immunotherapy improves pathological complete response rate and event-free survival in patients with resectable non-small-cell lung cancer (NSCLC), versus chemotherapy alone. NeoCOAST was the first randomized, multi-drug, platform trial to examine novel neoadjuvant immuno-oncology combinations for patients with resectable NSCLC, using major pathological response (MPR) as the primary endpoint. Eighty-three patients received a single cycle of treatment: 26 received durvalumab (anti-PD-L1) monotherapy, 21 received durvalumab plus oleclumab (anti-CD73), 20 received durvalumab plus monalizumab (anti-NKG2A), and 16 received durvalumab plus danvatirsen (anti-STAT3 antisense oligonucleotide). MPR rates were higher for patients in the combination arms, versus durvalumab alone. Safety profiles for the combinations were similar to that of durvalumab alone. Multiplatform immune profiling suggested improved MPR rates in the durvalumab plus oleclumab and durvalumab plus monalizumab arms were associated with enhanced effector immune infiltration of tumors, interferon responses and markers of tertiary lymphoid structure formation, and systemic functional immune-cell activation." @default.
- W4386725951 created "2023-09-15" @default.
- W4386725951 creator A5010423488 @default.
- W4386725951 creator A5018054038 @default.
- W4386725951 creator A5018203729 @default.
- W4386725951 creator A5020433600 @default.
- W4386725951 creator A5027200818 @default.
- W4386725951 creator A5032412092 @default.
- W4386725951 creator A5035685178 @default.
- W4386725951 creator A5041696291 @default.
- W4386725951 creator A5044613951 @default.
- W4386725951 creator A5049486044 @default.
- W4386725951 creator A5050859911 @default.
- W4386725951 creator A5053833659 @default.
- W4386725951 creator A5055246540 @default.
- W4386725951 creator A5055885018 @default.
- W4386725951 creator A5056510071 @default.
- W4386725951 creator A5059543131 @default.
- W4386725951 creator A5062198066 @default.
- W4386725951 creator A5065865976 @default.
- W4386725951 creator A5065920207 @default.
- W4386725951 creator A5068913222 @default.
- W4386725951 creator A5070560102 @default.
- W4386725951 creator A5074947833 @default.
- W4386725951 creator A5076345819 @default.
- W4386725951 creator A5079990493 @default.
- W4386725951 creator A5082321885 @default.
- W4386725951 creator A5082545687 @default.
- W4386725951 creator A5088587850 @default.
- W4386725951 creator A5088647694 @default.
- W4386725951 date "2023-09-14" @default.
- W4386725951 modified "2023-09-27" @default.
- W4386725951 title "Neoadjuvant Durvalumab Alone or Combined with Novel Immuno-Oncology Agents in Resectable Lung Cancer: The Phase 2 NeoCOAST Platform Trial" @default.
- W4386725951 doi "https://doi.org/10.1158/2159-8290.cd-23-0436" @default.
- W4386725951 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37707791" @default.
- W4386725951 hasPublicationYear "2023" @default.
- W4386725951 type Work @default.
- W4386725951 citedByCount "0" @default.
- W4386725951 crossrefType "journal-article" @default.
- W4386725951 hasAuthorship W4386725951A5010423488 @default.
- W4386725951 hasAuthorship W4386725951A5018054038 @default.
- W4386725951 hasAuthorship W4386725951A5018203729 @default.
- W4386725951 hasAuthorship W4386725951A5020433600 @default.
- W4386725951 hasAuthorship W4386725951A5027200818 @default.
- W4386725951 hasAuthorship W4386725951A5032412092 @default.
- W4386725951 hasAuthorship W4386725951A5035685178 @default.
- W4386725951 hasAuthorship W4386725951A5041696291 @default.
- W4386725951 hasAuthorship W4386725951A5044613951 @default.
- W4386725951 hasAuthorship W4386725951A5049486044 @default.
- W4386725951 hasAuthorship W4386725951A5050859911 @default.
- W4386725951 hasAuthorship W4386725951A5053833659 @default.
- W4386725951 hasAuthorship W4386725951A5055246540 @default.
- W4386725951 hasAuthorship W4386725951A5055885018 @default.
- W4386725951 hasAuthorship W4386725951A5056510071 @default.
- W4386725951 hasAuthorship W4386725951A5059543131 @default.
- W4386725951 hasAuthorship W4386725951A5062198066 @default.
- W4386725951 hasAuthorship W4386725951A5065865976 @default.
- W4386725951 hasAuthorship W4386725951A5065920207 @default.
- W4386725951 hasAuthorship W4386725951A5068913222 @default.
- W4386725951 hasAuthorship W4386725951A5070560102 @default.
- W4386725951 hasAuthorship W4386725951A5074947833 @default.
- W4386725951 hasAuthorship W4386725951A5076345819 @default.
- W4386725951 hasAuthorship W4386725951A5079990493 @default.
- W4386725951 hasAuthorship W4386725951A5082321885 @default.
- W4386725951 hasAuthorship W4386725951A5082545687 @default.
- W4386725951 hasAuthorship W4386725951A5088587850 @default.
- W4386725951 hasAuthorship W4386725951A5088647694 @default.
- W4386725951 hasBestOaLocation W43867259511 @default.
- W4386725951 hasConcept C121608353 @default.
- W4386725951 hasConcept C126322002 @default.
- W4386725951 hasConcept C143998085 @default.
- W4386725951 hasConcept C203014093 @default.
- W4386725951 hasConcept C203092338 @default.
- W4386725951 hasConcept C2776256026 @default.
- W4386725951 hasConcept C2776694085 @default.
- W4386725951 hasConcept C2777701055 @default.
- W4386725951 hasConcept C2777742743 @default.
- W4386725951 hasConcept C2780030458 @default.
- W4386725951 hasConcept C2780140570 @default.
- W4386725951 hasConcept C502942594 @default.
- W4386725951 hasConcept C535046627 @default.
- W4386725951 hasConcept C71924100 @default.
- W4386725951 hasConcept C8891405 @default.
- W4386725951 hasConceptScore W4386725951C121608353 @default.
- W4386725951 hasConceptScore W4386725951C126322002 @default.
- W4386725951 hasConceptScore W4386725951C143998085 @default.
- W4386725951 hasConceptScore W4386725951C203014093 @default.
- W4386725951 hasConceptScore W4386725951C203092338 @default.
- W4386725951 hasConceptScore W4386725951C2776256026 @default.
- W4386725951 hasConceptScore W4386725951C2776694085 @default.
- W4386725951 hasConceptScore W4386725951C2777701055 @default.
- W4386725951 hasConceptScore W4386725951C2777742743 @default.
- W4386725951 hasConceptScore W4386725951C2780030458 @default.
- W4386725951 hasConceptScore W4386725951C2780140570 @default.
- W4386725951 hasConceptScore W4386725951C502942594 @default.
- W4386725951 hasConceptScore W4386725951C535046627 @default.
- W4386725951 hasConceptScore W4386725951C71924100 @default.
- W4386725951 hasConceptScore W4386725951C8891405 @default.
- W4386725951 hasLocation W43867259511 @default.
- W4386725951 hasLocation W43867259512 @default.